LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $22,769,074 | +32.0% | 270,224 | +14.5% | 0.01% | +25.0% |
Q1 2024 | $17,244,582 | +29.9% | 235,904 | +26.9% | 0.01% | +14.3% |
Q4 2023 | $13,276,764 | +62.6% | 185,897 | +36.5% | 0.01% | +40.0% |
Q3 2023 | $8,162,842 | +18.8% | 136,229 | +43.0% | 0.01% | +25.0% |
Q2 2023 | $6,869,040 | -3.2% | 95,271 | -1.3% | 0.00% | 0.0% |
Q1 2023 | $7,098,688 | +110.3% | 96,502 | +91.0% | 0.00% | +100.0% |
Q4 2022 | $3,375,204 | -19.4% | 50,527 | +3.9% | 0.00% | -33.3% |
Q3 2022 | $4,186,000 | -6.3% | 48,608 | -2.9% | 0.00% | +50.0% |
Q2 2022 | $4,466,000 | -22.0% | 50,059 | -1.7% | 0.00% | -33.3% |
Q1 2022 | $5,727,000 | -48.1% | 50,904 | -28.8% | 0.00% | -40.0% |
Q4 2021 | $11,036,000 | +27.8% | 71,454 | +15.3% | 0.01% | +25.0% |
Q3 2021 | $8,632,000 | -12.4% | 61,960 | -17.5% | 0.00% | -20.0% |
Q2 2021 | $9,852,000 | -22.0% | 75,098 | -9.4% | 0.01% | -28.6% |
Q1 2021 | $12,636,000 | +49.3% | 82,885 | -2.6% | 0.01% | +40.0% |
Q4 2020 | $8,461,000 | +5.5% | 85,073 | +1.1% | 0.01% | -16.7% |
Q3 2020 | $8,017,000 | -29.7% | 84,114 | -17.6% | 0.01% | -33.3% |
Q2 2020 | $11,412,000 | +63.5% | 102,024 | +6.3% | 0.01% | +50.0% |
Q1 2020 | $6,979,000 | -13.5% | 95,975 | +24.1% | 0.01% | +20.0% |
Q4 2019 | $8,066,000 | +35.7% | 77,353 | +29.5% | 0.01% | +25.0% |
Q3 2019 | $5,946,000 | +6.0% | 59,751 | +21.5% | 0.00% | +33.3% |
Q2 2019 | $5,608,000 | -29.3% | 49,160 | -22.1% | 0.00% | -40.0% |
Q1 2019 | $7,933,000 | -55.5% | 63,135 | -52.0% | 0.01% | -61.5% |
Q4 2018 | $17,834,000 | -76.4% | 131,438 | -52.3% | 0.01% | -40.9% |
Q3 2018 | $75,642,000 | -57.4% | 275,573 | -67.8% | 0.02% | -56.9% |
Q2 2018 | $177,555,000 | +155.0% | 857,065 | +103.3% | 0.05% | +54.5% |
Q1 2018 | $69,633,000 | +7.9% | 421,633 | -10.6% | 0.03% | -19.5% |
Q4 2017 | $64,549,000 | -7.7% | 471,423 | -8.2% | 0.04% | -14.6% |
Q3 2017 | $69,930,000 | +0.9% | 513,641 | -10.1% | 0.05% | -2.0% |
Q2 2017 | $69,326,000 | +12.9% | 571,067 | -1.6% | 0.05% | +8.9% |
Q1 2017 | $61,397,000 | +18.7% | 580,117 | +14.0% | 0.04% | +7.1% |
Q4 2016 | $51,704,000 | +8.4% | 508,870 | +8.9% | 0.04% | +23.5% |
Q3 2016 | $47,698,000 | -9.9% | 467,378 | +5.2% | 0.03% | -8.1% |
Q2 2016 | $52,966,000 | +9.6% | 444,098 | -1.6% | 0.04% | +2.8% |
Q1 2016 | $48,334,000 | +13.9% | 451,355 | +15.3% | 0.04% | +24.1% |
Q4 2015 | $42,451,000 | +25.3% | 391,562 | -1.0% | 0.03% | +11.5% |
Q3 2015 | $33,876,000 | +7.6% | 395,558 | +26.8% | 0.03% | +30.0% |
Q2 2015 | $31,480,000 | +30.1% | 312,021 | -0.6% | 0.02% | +33.3% |
Q1 2015 | $24,191,000 | +38.3% | 313,747 | -4.6% | 0.02% | +36.4% |
Q4 2014 | $17,497,000 | +3.2% | 328,866 | -8.8% | 0.01% | 0.0% |
Q3 2014 | $16,947,000 | +215.7% | 360,677 | +318.4% | 0.01% | +175.0% |
Q2 2014 | $5,368,000 | +21.3% | 86,199 | +31.1% | 0.00% | +33.3% |
Q1 2014 | $4,424,000 | -32.4% | 65,770 | -47.1% | 0.00% | -40.0% |
Q4 2013 | $6,542,000 | -64.0% | 124,422 | -70.4% | 0.01% | -61.5% |
Q3 2013 | $18,158,000 | – | 419,645 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |